Free Trial

AIkido Pharma (AIKI) Competitors

AIkido Pharma logo
$5.27 -0.13 (-2.41%)
As of 06/9/2025

AIKI vs. LUNA, ONMD, BIAF, ISPC, DKDCA, IQV, INCY, ICLR, MEDP, and CRL

Should you be buying AIkido Pharma stock or one of its competitors? The main competitors of AIkido Pharma include Luna Innovations (LUNA), OneMedNet (ONMD), bioAffinity Technologies (BIAF), iSpecimen (ISPC), Data Knights Acquisition (DKDCA), IQVIA (IQV), Incyte (INCY), ICON Public (ICLR), Medpace (MEDP), and Charles River Laboratories International (CRL). These companies are all part of the "commercial physical research" industry.

AIkido Pharma vs.

AIkido Pharma (NASDAQ:AIKI) and Luna Innovations (NASDAQ:LUNA) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their community ranking, profitability, earnings, valuation, media sentiment, analyst recommendations, risk, institutional ownership and dividends.

AIkido Pharma has a beta of 0.93, indicating that its share price is 7% less volatile than the S&P 500. Comparatively, Luna Innovations has a beta of 1.88, indicating that its share price is 88% more volatile than the S&P 500.

Luna Innovations received 98 more outperform votes than AIkido Pharma when rated by MarketBeat users. However, 63.92% of users gave AIkido Pharma an outperform vote while only 54.97% of users gave Luna Innovations an outperform vote.

CompanyUnderperformOutperform
AIkido PharmaOutperform Votes
101
63.92%
Underperform Votes
57
36.08%
Luna InnovationsOutperform Votes
199
54.97%
Underperform Votes
163
45.03%

Luna Innovations has higher revenue and earnings than AIkido Pharma.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AIkido Pharma$10K2,890.60-$7.17M-$3.88-1.36
Luna Innovations$116.61M0.22$9.28MN/AN/A

10.9% of AIkido Pharma shares are held by institutional investors. Comparatively, 87.5% of Luna Innovations shares are held by institutional investors. 8.6% of AIkido Pharma shares are held by company insiders. Comparatively, 7.6% of Luna Innovations shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Luna Innovations had 3 more articles in the media than AIkido Pharma. MarketBeat recorded 3 mentions for Luna Innovations and 0 mentions for AIkido Pharma. Luna Innovations' average media sentiment score of 0.42 beat AIkido Pharma's score of 0.00 indicating that Luna Innovations is being referred to more favorably in the news media.

Company Overall Sentiment
AIkido Pharma Neutral
Luna Innovations Neutral

Luna Innovations' return on equity of 0.00% beat AIkido Pharma's return on equity.

Company Net Margins Return on Equity Return on Assets
AIkido PharmaN/A -18.21% -16.94%
Luna Innovations N/A N/A N/A

Summary

Luna Innovations beats AIkido Pharma on 9 of the 12 factors compared between the two stocks.

Get AIkido Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for AIKI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AIKI vs. The Competition

MetricAIkido PharmaCommercial physical research IndustryMedical SectorNASDAQ Exchange
Market Cap$28.91M$3.36B$5.57B$8.67B
Dividend YieldN/A2.24%5.27%4.19%
P/E Ratio-1.36122.0627.2020.17
Price / Sales2,890.60161.53412.92161.90
Price / CashN/A34.5738.2534.64
Price / Book0.272.597.114.72
Net Income-$7.17M$118.81M$3.23B$247.80M
7 Day Performance17.63%5.65%4.61%3.36%
1 Month Performance-12.02%11.26%13.35%9.71%
1 Year Performance150.95%-16.36%31.75%14.41%

AIkido Pharma Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AIKI
AIkido Pharma
N/A$5.27
-2.4%
N/A+159.1%$28.91M$10,000.00-1.364High Trading Volume
LUNA
Luna Innovations
0.4277 of 5 stars
$0.75
+7.1%
N/A-78.7%$25.47M$116.61M0.00390Gap Down
ONMD
OneMedNet
0.2069 of 5 stars
$0.37
-3.9%
N/A-74.3%$11.16M$532,000.00-1.112Gap Down
BIAF
bioAffinity Technologies
2.4466 of 5 stars
$0.28
+7.6%
$6.00
+2,023.1%
-87.5%$7.90M$8.81M-0.3410Gap Up
ISPC
iSpecimen
0.6314 of 5 stars
$1.28
+9.9%
N/A+218.4%$3.18M$8.06M-0.0760
DKDCA
Data Knights Acquisition
N/A$0.38
-5.0%
N/A-77.9%$1.97MN/A-2.002Gap Down
High Trading Volume
IQV
IQVIA
4.9162 of 5 stars
$142.74
+2.6%
$226.32
+58.5%
-29.7%$24.69B$15.50B19.0386,000Positive News
INCY
Incyte
4.302 of 5 stars
$67.11
+2.8%
$72.53
+8.1%
+18.1%$12.99B$4.41B248.562,320Positive News
High Trading Volume
ICLR
ICON Public
4.3849 of 5 stars
$133.76
+3.8%
$213.08
+59.3%
-56.2%$10.80B$8.19B14.0441,100
MEDP
Medpace
4.7151 of 5 stars
$306.07
+2.8%
$349.30
+14.1%
-25.6%$8.80B$2.16B24.235,200Positive News
CRL
Charles River Laboratories International
4.4661 of 5 stars
$138.71
+2.7%
$171.85
+23.9%
-31.3%$6.81B$4.02B924.7521,400

Related Companies and Tools


This page (NASDAQ:AIKI) was last updated on 6/10/2025 by MarketBeat.com Staff
From Our Partners